Top Markets
#1 Fake World Assets Fake World Assets +11.84%
#2 TENDIES TENDIES +6.51%
#3 Janction Janction +5.07%
#4 GoPlus Security GoPlus Security +4.45%
#5 B3 (Base) B3 (Base) +4.30%
#6 Status Status +4.24%
#7 Everything Everything +3.72%
#8 TronBank TronBank +3.26%
#9 Cross Cross +2.99%
#10 Tutorial Tutorial +2.63%
Coin of the day
Fake World Assets Fake World Assets
設定
言語
日本
通貨
USD
テーマ
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
株式のランク #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
株価
$0.617
最終同期: 2024-10-14
時価総額
$6.13M
変化（1日）
0.49%
変化（1年）
0.00%
国
US
取引 Kineta, Inc. (KA)

カテゴリー

Healthcare
Kineta, Inc.（KA）の配当履歴
Kineta, Inc.（証券コード：KA）は合計で1回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：$10.01
配当利回り（TTM）：0
2022から2026までのKineta, Inc.（KA）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
2026 (TTM) $10.01 0.00%
2022 $10.01 0.00%
すべての配当支払いの一覧
年 配当 変化
2026 (TTM) $10.01 0.00%
2022 $10.01 0.00%
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE